TORNTPHARMNSETorrent Pharmaceuticals Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 9 Jun · 20:03 IST

Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Torrent Pharmaceuticals has been assigned an Environmental, Social, and Governance (ESG) rating of 65 by NSE Sustainability Ratings & Analytics Limited, a SEBI-registered ESG Rating Provider. The rating was received by the company on 6th June 2025 after working hours, and the disclosure to the stock exchanges was made on 9th June 2025, the first working day after receipt. The filing is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. An ESG score of 65 reflects a moderate-to-good standing on environmental, social, and governance parameters.

Likely market impact

This is a routine ESG rating disclosure with no material financial impact. It signals the company's commitment to sustainability practices, which may appeal to ESG-focused institutional investors, but is unlikely to cause any significant short-term movement in the stock price.